Articles

Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.

Stock investors emphasize interest-rate trends and investor sentiment.

AI mastery could cement Tesla’s lead in autonomous driving and beyond.

Companies are spending big to develop their own AI chips so they don’t have to keep paying Nvidia.

Oil futures moved lower early Monday, slipping after Hamas over the weekend gave its initial approval of a U.S.-backed proposal for a phased cease-fire deal with Israel in Gaza.

The battle has been waged since last October when Vista announced it would separate its ammunition business from Revelyst, its outdoor-products business of golfing, fishing equipment and branded biking.

Ed Yardeni offers three important reasons why investors should be less worried.

“What are the tax and financial implications of receiving an estate and then passing on a large percentage of it to someone else?”

Bond yields edged higher on Monday as investors prepared for vital inflation data later in the week.

Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.

Hedge funds were net buyers of energy and materials stocks for the third week in a row, Goldman Sachs’ analysis shows

This Wright-designed Usonian-style home underwent an $800,000 restoration.